Symposium 3-1. Occult Hepatitis Virus Infection and Post-Cure Virologic Failure

Patrick Kennedy (Queen Mary Univ. of London, UK), Kwan Sik Lee (CHA Univ., Korea)

  • 08:30-08:45
  • A Twist to a Cure of HCV Infection: Occult HCV Infection

    Atsumasa Komori (Nagasaki Univ., Japan)

  • 08:45-09:00
  • Re-Infection of HCV Post-SVR

    Ki Tae Yoon (Pusan National Univ., Korea)

  • 09:00-09:15
  • Occult HBV Infection: The Fate and Clinical Implications

    Man-Fung Yuen (The Univ. of Hong Kong, Hong Kong)

  • 09:15-09:30
  • Threat: HBV Reactivation after Resolved Hepatitis B

    Su Jong Yu (Seoul National Univ., Korea)


Keynote Lecture 3. What Happens to the Liver after a Cure of Viral Hepatitis?

Man-Fung Yuen (The Univ. of Hong Kong, Hong Kong), Marc G. Ghany (NIH, USA)

  • 09:30-09:50
  • cccDNA and HBV Functional Cure Is CccDNA the Chicken or the Egg?

    Robert G. Gish (Hepatitis B Foundation, USA)

  • 09:50-10:10
  • HBV Integration as a Novel Biomarker and Barrier to a Cure for HBV Infection

    Patrick Kennedy (Queen Mary Univ. of London, UK)

  • 10:10-10:30
  • Immune Reconstitution after HCV Clearance with Direct Antiviral Agents

    Tatsuya Kanto (National Center for Global Health and Medicine, Japan)

  • 10:30-10:50
  • Coffee Break


State-of-the-Art Lecture 3.

Shiv Kumar Sarin (Institute of Liver & Biliary Sciences, India)

  • 10:50-11:20
  • A Roadmap to Eliminating Viral Hepatitis

    Norah Terrault (Univ. of Southern California, USA)


Debrief Session

Jeong Won Jang (The Catholic Univ. of Korea, Korea)

  • 11:20-11:30
  • Viral Hepatitis Debrief

    Hye Won Lee (Yonsei Univ., Korea)

  • 11:30-11:40
  • Non-Viral Liver Disease Debrief

    Pil Soo Sung (The Catholic Univ. of Korea, Korea)

  • 11:40-11:50
  • Wrap-Up

    Jeong Won Jang (The Catholic Univ. of Korea, Korea)

  • 11:50-12:20
  • Closing & Award Ceremony


Symposium 3-2. Precision Medicine for the Cure of Viral Liver Disease

W. Ray Kim (Stanford Univ., USA), Joon Hyoek Lee (Sungkyunkwan Univ., Korea)

  • 08:30-08:45
  • Personalized Management of Viral Hepatitis of the Present and the Future

    Maria Buti Ferret (Hospital Universitario Valle Hebron, Spain)

  • 08:45-09:00
  • Risk Stratification for HCC in Chronic Hepatitis B: A Promise for Precision Medicine

    Won Sohn (Sungkyunkwan Univ., Korea)

  • 09:00-09:15
  • Host and Genetic Factors for Precision Medicine towards a Cure of Viral Hepatitis

    Kazuaki Chayama (Hiroshima Univ., Japan)

  • 09:15-09:30
  • Biomarker Discovery and Application for Liver Disease in the Era of Precision Medicine

    Sun Young Yim (Korea Univ., Korea)


Early Morning Workshop 3. Fibrosis Regression after Antiviral Therapy in Patients with Chronic Viral Hepatitis

Atsumasa Komori (Nagasaki Univ., Japan)

  • 07:30-07:42
  • Fibrosis Regression after HCV Treatment and Its Clinical Significance

    Jeong-Ju Yoo (Soonchunhyang Univ., Korea)

  • 07:42-07:54
  • Clinical Implication of On-Therapy Fibrosis Regression in Chronic Hepatitis B

    Mi Na Kim (Yonsei Univ., Korea)

  • 07:54-08:20
  • Discussion

    Discussant: Jeong-Ju Yoo (Soonchunhyang Univ., Korea), Mi Na Kim (Yonsei Univ., Korea), Sung Jae Park (Inje Univ., Korea), Roongruedee Chaiteerakij (Chulalongkorn Univ., Thailand)


Early Morning Workshop 4. Screening and Prognosis of HDV Infection with Case Discussion

Jose D. Sollano (The Univ. of Santo Tomas, Philippines)

  • 07:30-07:37
  • Threat: Who Should Be Screened for HDV Infection? - Case Presentation

    Hee Yeon Kim (The Catholic Univ. of Korea, Korea)

  • 07:37-07:45
  • Who Should Be Screened for HDV Infection?

    Jae Hyun Yoon (Chonnam National Univ., Korea)

  • 07:45-07:57
  • Prognosis of HDV: Risk Factors and Whom to Treat

    Lubna Kamani (Liaquat National Hospital, Pakistan)

  • 07:57-08:20
  • Discussion

    Discussants: Hee Yeon Kim (The Catholic Univ. of Korea, Korea), Jae Hyun Yoon (Chonnam National Univ, Korea), Lubna Kamani (Liaquat National Hospital, Pakistan), Ji Hoon Kim (Korea Univ., Korea)